| Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College … S Roy, C Coldren, A Karunamurthy, NS Kip, EW Klee, SE Lincoln, A Leon, ... The Journal of Molecular Diagnostics 20 (1), 4-27, 2018 | 440 | 2018 |
| 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate … Y Chen, M Pullambhatla, CA Foss, Y Byun, S Nimmagadda, ... Clinical cancer research 17 (24), 7645-7653, 2011 | 417 | 2011 |
| 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, G Green, JJ Fox, ... Journal of medicinal chemistry 53 (14), 5333-5341, 2010 | 308 | 2010 |
| Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer Y Chen, CA Foss, Y Byun, S Nimmagadda, M Pullambhatla, JJ Fox, ... Journal of medicinal chemistry 51 (24), 7933-7943, 2008 | 278 | 2008 |
| A low molecular weight PSMA-based fluorescent imaging agent for cancer Y Chen, S Dhara, SR Banerjee, Y Byun, M Pullambhatla, RC Mease, ... Biochemical and biophysical research communications 390 (3), 624-629, 2009 | 188 | 2009 |
| Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, CA Foss, ... Angewandte Chemie (International ed. in English) 50 (39), 9167, 2011 | 160 | 2011 |
| 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer SR Banerjee, M Pullambhatla, CA Foss, S Nimmagadda, R Ferdani, ... Journal of medicinal chemistry 57 (6), 2657-2669, 2014 | 158 | 2014 |
| Molecular Imaging of CXCR4 Receptor Expression in Human Cancer Xenografts with [64Cu]AMD3100 Positron Emission Tomography S Nimmagadda, M Pullambhatla, K Stone, G Green, ZM Bhujwalla, ... Cancer research 70 (10), 3935-3944, 2010 | 155 | 2010 |
| Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen Y Chen, M Pullambhatla, SR Banerjee, Y Byun, M Stathis, C Rojas, ... Bioconjugate chemistry 23 (12), 2377-2385, 2012 | 135 | 2012 |
| Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen AP Kiess, I Minn, Y Chen, R Hobbs, G Sgouros, RC Mease, ... Journal of Nuclear Medicine 56 (9), 1401-1407, 2015 | 123 | 2015 |
| Bioisosterism of urea-based GCPII inhibitors: synthesis and structure–activity relationship studies H Wang, Y Byun, C Barinka, M Pullambhatla, CB Hyo-eun, JJ Fox, ... Bioorganic & medicinal chemistry letters 20 (1), 392-397, 2010 | 106 | 2010 |
| Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA) S Ray Banerjee, M Pullambhatla, CA Foss, A Falk, Y Byun, ... Journal of medicinal chemistry 56 (15), 6108-6121, 2013 | 105 | 2013 |
| Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465 RA De Silva, K Peyre, M Pullambhatla, JJ Fox, MG Pomper, ... Journal of Nuclear Medicine 52 (6), 986-993, 2011 | 100 | 2011 |
| A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA) SR Banerjee, M Pullambhatla, H Shallal, A Lisok, RC Mease, MG Pomper Oncotarget 2 (12), 1244, 2011 | 89 | 2011 |
| Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT S Nimmagadda, M Pullambhatla, MG Pomper Journal of Nuclear Medicine 50 (7), 1124-1130, 2009 | 84 | 2009 |
| Preclinical Comparative Study of 68Ga-Labeled DOTA, NOTA, and HBED-CC Chelated Radiotracers for Targeting PSMA S Ray Banerjee, Z Chen, M Pullambhatla, A Lisok, J Chen, RC Mease, ... Bioconjugate chemistry 27 (6), 1447-1455, 2016 | 72 | 2016 |
| Synthesis and Evaluation of GdIII‐Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate‐Specific Membrane Antigen SR Banerjee, EJ Ngen, MW Rotz, S Kakkad, A Lisok, R Pracitto, ... Angewandte Chemie International Edition 54 (37), 10778-10782, 2015 | 71 | 2015 |
| Clinical significance of DNA variants in chronic myeloid neoplasms: a report of the Association for Molecular Pathology RF McClure, MD Ewalt, J Crow, RL Temple-Smolkin, M Pullambhatla, ... The Journal of Molecular Diagnostics 20 (6), 717-737, 2018 | 67 | 2018 |
| 111In- and IRDye800CW-Labeled PLA–PEG Nanoparticle for Imaging Prostate-Specific Membrane Antigen-Expressing Tissues SR Banerjee, CA Foss, A Horhota, M Pullambhatla, K McDonnell, S Zale, ... Biomacromolecules 18 (1), 201-209, 2017 | 54 | 2017 |
| A PSMA-targeted theranostic agent for photodynamic therapy Y Chen, S Chatterjee, A Lisok, I Minn, M Pullambhatla, B Wharram, ... Journal of Photochemistry and Photobiology B: Biology 167, 111-116, 2017 | 49 | 2017 |
